Starting this Thursday, reusable menstrual pants and menstrual pads sold in pharmacies in France will be eligible for reimbursement by the national Social Security system and private insurance companies. This initiative is intended to address menstrual precarity, a condition that currently affects more than one in ten women, who are forced to use makeshift solutions due to financial constraints. The program specifically targets young women under the age of 26 and those receiving the Solidarity Health Insurance Supplement, a group numbering approximately 6.7 million people in France. To receive reimbursement without paying out-of-pocket, individuals must present their Vitale card and insurance certificate at the pharmacy, with up to two reimbursable products allowed per year and per person. An ordinance published in the Official Journal of the French government sets strict guidelines for the products that qualify for reimbursement. Menstrual pants must have at least three distinct layers, provide a minimum absorption capacity of 20 milliliters, and be able to withstand at least 52 washes at 30 degrees Celsius. Manufacturers are also required to offer at least eight different sizes, with a retail price in the pharmacy capped at 14.40 euros before tax, or 19 euros including tax. For French manufacturers, this new policy presents a major logistical challenge, especially with the competition from low-cost products imported from Asia. In the Gard region, the factory of the Eminence group in Sauve, a partner of the brand Elia, has adapted its production line to make 2,000 pants per day, compared to 2,000 per month under normal circumstances. While co-founder Marion Goilav and site director Kader Lasla welcome this historic social advancement, they express concern over the minimal requirements set in the specification sheet, which they believe could weaken French companies that manufacture locally. The policy reflects a growing awareness of menstrual health as a public health issue and an effort to make period care more accessible and affordable. However, the implementation of the program highlights the complex balance between supporting innovation and ensuring that domestic producers can compete in a global market.